MEMORIAL DAY FLASH SALE: 50% OFF BENZINGA PRO
As we honor our freedom, take a stand today. Secure the financial freedom that both you and your family deserve. Get exclusive market moving news for just 50% off. Claim your 50% discount here.
Emergent BioSolutions (NYSE:EBS) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Emergent BioSolutions missed estimated earnings by 155.65%, reporting an EPS of $-3.17 versus an estimate of $-1.24.
Revenue was down $142.40 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.35 which was followed by a 11.57% drop in the share price the next day.
Here's a look at Emergent BioSolutions's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.04 | -0.06 | 0.37 | 0.12 |
| EPS Actual | -0.31 | -1.27 | -0.86 | 0.18 |
| Revenue Estimate | 296.62M | 268.30M | 270.94M | 283.00M |
| Revenue Actual | 330.70M | 240.00M | 242.70M | 307.50M |
To track all earnings releases for Emergent BioSolutions visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
MEMORIAL DAY FLASH SALE: 50% OFF BENZINGA PRO
As we honor our freedom, take a stand today. Secure the financial freedom that both you and your family deserve. Get exclusive market moving news for just 50% off. Claim your 50% discount here.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!